IL6 and breast cancer: Niches formed by these CAFs foster the survival of CSCs, providing constant IL-6 and IL-8 secretion, which leads to persistent NF-kB signaling in BC cells and protects them from chemotherapy-induced cell death (88), regulating ABCG2 transporter expression.